Moreover, the response of lung cancer cells to EGFR inhibitors and radiation could be attenuated by changes in p53 expression, as shown in p53 knockdown in parental cells and p53 functional restoration in resistant cells [13]. The gene discussed is TP53; the disease is lung cancer.